André Ferreira Moreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
André Ferreira Moreira has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Ilídio Joaquim Correia
RISE-Health, Departamento de Ciências Médicas, Faculdade de Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal; AEROG-LAETA, Aerospace Sciences Department, Universidade da Beira Interior, Covilhã, Portugal; University of Coimbra, CERES - Centro de Engenharia Química e Recursos Renováveis para a Sustentabilidade, Department of Chemical Engineering, Coimbra 3030-790, Portugal
54 shared publications - Duarte de Melo-Diogo
CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal
23 shared publications - Sonia P. Miguel
BRIDGES ‐ Biotechnology Research Innovation and Design for Health Products Polytechnic of Guarda Guarda Portugal
14 shared publications - Carolina F. Rodrigues
CICS-UBI - Health Sciences Research Centre, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal
13 shared publications Elisabete C. Costa
CICS-UBI - Health Sciences Research Centre, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
12 shared publications- Paula Ferreira
Department of Chemical Engineering CERES University of Coimbra Coimbra Portugal
12 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 127
Development of a dual-layer near-infrared-responsive hydrogel/membrane wound dressing for enhanced healing
- 2 September 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 127
Open AccessDevelopment of a dual-layer near-infrared-responsive hydrogel/membrane wound dressing for enhanced healing
- Open Access
- 26 August 2026
- Published by ScienceOpen
Similar Kinases, Distinct Hits: In Silico Repurposing of FDA-Approved Drugs for ALK and ROS1
- 26 August 2026
- Published by ScienceOpen
Open AccessSimilar Kinases, Distinct Hits: In Silico Repurposing of FDA-Approved Drugs for ALK and ROS1
- Open Access
- 3 August 2026
- Published by ScienceOpen
RePo-SUDOE – Advances on the transnational network for drug repurposing in the SUDOE space
- 3 August 2026
- Published by ScienceOpen
Open AccessRePo-SUDOE – Advances on the transnational network for drug repurposing in the SUDOE space
- Open Access
- 19 June 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 188, 215022
Impact of silk-derived sericin on the formation and metformin sensitivity of breast cancer-fibroblast heterotypic spheroids
- 19 June 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 188, 215022
Open AccessImpact of silk-derived sericin on the formation and metformin sensitivity of breast cancer-fibroblast heterotypic spheroids
- Open Access
- 14 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (22) , 20039-20050
Photothermal activity in cancer therapy and antimicrobial properties of green gold nanoparticles from winery waste
Nanomaterial-mediated photothermal therapy is an emerging approach to cancer care; however, the required biocompatibility of nanoparticles remains a critical aspect. To enhance their biocompatibility, biocompatible sources can be used in nanoparticle preparation instead of the conventional toxic substances that are generally required. To this end, grape marc, obtained as agricultural waste from the winery industry, was chosen as an important source of natural compounds. By modifying the nanoparticle surface, it can form a crucial interface with the surrounding environment. In this work, green gold nanoparticles were synthesized and applied in photothermal therapy, and their biocompatibility, antitumor, and antibacterial properties were evaluated. Reducing sugars and polyphenolic compounds, naturally occurring in grape marc waste, were extracted in water and successfully employed in the preparation of gold nanoparticles, as confirmed by the appearance of a plasmonic band at 535 nm. A second peak at 286 nm, typical of phenolic groups, demonstrated the presence of a polyphenolic layer on the nanoparticle surface, which was also confirmed in FTIR studies. TEM and XRD analyses revealed their crystalline nature, with an average diameter of about 30 nm. A third absorption peak in the near-infrared region (750 nm) shows that the synthesized gold nanoparticles can be good photothermal agents with a temperature increase of about 22 °C after 10 minutes of NIR laser irradiation (808 nm and 1.7 W cm−2). Good biocompatibility with human fibroblasts and breast cancer cells (MCF-7) was also demonstrated at high concentrations (400 µg mL−1), with the cell viability remaining above 70% during 72 hours of incubation. Antibacterial and antitumoral effects of the synthesized nanoparticles were observed after NIR laser irradiation, with 41.7% and 52.5% cell viability inhibition in S. aureus and E. coli, respectively, at higher concentrations, and a reduction of MCF-7 cell viability to 37%.
- 14 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (22) , 20039-20050
Open AccessPhotothermal activity in cancer therapy and antimicrobial properties of green gold nanoparticles from winery waste
Nanomaterial-mediated photothermal therapy is an emerging approach to cancer care; however, the required biocompatibility of nanoparticles remains a critical aspect. To enhance their biocompatibility, biocompatible sources can be used in nanoparticle preparation instead of the conventional toxic substances that are generally required. To this end, grape marc, obtained as agricultural waste from the winery industry, was chosen as an important source of natural compounds. By modifying the nanoparticle surface, it can form a crucial interface with the surrounding environment. In this work, green gold nanoparticles were synthesized and applied in photothermal therapy, and their biocompatibility, antitumor, and antibacterial properties were evaluated. Reducing sugars and polyphenolic compounds, naturally occurring in grape marc waste, were extracted in water and successfully employed in the preparation of gold nanoparticles, as confirmed by the appearance of a plasmonic band at 535 nm. A second peak at 286 nm, typical of phenolic groups, demonstrated the presence of a polyphenolic layer on the nanoparticle surface, which was also confirmed in FTIR studies. TEM and XRD analyses revealed their crystalline nature, with an average diameter of about 30 nm. A third absorption peak in the near-infrared region (750 nm) shows that the synthesized gold nanoparticles can be good photothermal agents with a temperature increase of about 22 °C after 10 minutes of NIR laser irradiation (808 nm and 1.7 W cm−2). Good biocompatibility with human fibroblasts and breast cancer cells (MCF-7) was also demonstrated at high concentrations (400 µg mL−1), with the cell viability remaining above 70% during 72 hours of incubation. Antibacterial and antitumoral effects of the synthesized nanoparticles were observed after NIR laser irradiation, with 41.7% and 52.5% cell viability inhibition in S. aureus and E. coli, respectively, at higher concentrations, and a reduction of MCF-7 cell viability to 37%.
- Open Access
- 5 February 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14
Development of gold nanoparticles stabilized by PLGA and PVA for application in photothermal therapy
Introduction: In today's world, cancer remains a major public health problem. Consequently, there has been a focused investigation of alternative therapeutic approaches to address this ongoing health concern. In this study, PLGA-gold nanomaterials were produced through various processes to determine whether these variations affected their structural integrity and, consequently, their physicochemical properties. Methods: The PLGA-gold nanomaterials were produced through an oil-in-water (O/W) process (Formulation A) or a water-in-oil-in-water (W1/O/W2) process (Formulation B). The nanomaterials' physiscochemical properties were characterized by electron microscopy, dynamic light scattering, and UV-vis. Photothermal studies were performed using a 808 nm NIR laser and the PLGA-gold nanomaterials cytocompatibility was evaluated using resazurin. Results: Both methods originated particles with similar size and charge, 276.8 and –19.6 mV for formulation A and 317.5 nm and –18.6 mV for formulation B. Nevertheless, the TEM images revealed structural differences, with formulation A presenting the gold spheres clustered in the particle nucleus, whereas in formulation B the gold spheres were found in the outer PLGA shell. Moreover, upon irradiation with a NIR laser (808 nm, 1.7 W cm–2, 10 min), the particles showed a concentration dependent photothermal effect, promoting a temperature increase of 21 °C and 13.9 °C for formulation A and B at 400 μg/mL, respectively. Additionally, preliminary cellular assays demonstrated that the PLGA-gold nanoparticles are cytocompatible, with both FibH and HeLa cells exhibiting a cellular viability of approximately 100%. Conclusion: Thus, these results underline the potential the PLGA-gold nanoparticles, particularly formulation A, for advanced applications in nanomedicine. In the future the encapsulation of drugs will be evaluated in order to characterise both the uptake and the cytotoxic capacity of this multifunctional nanomaterial. Additionally, the utilization of more complex in vitro models, such as tumor spheroids and animal models, will then be essential to determine the therapeutic potential of PLGA/gold nanoparticles.
- 5 February 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14
Open AccessDevelopment of gold nanoparticles stabilized by PLGA and PVA for application in photothermal therapy
Introduction: In today's world, cancer remains a major public health problem. Consequently, there has been a focused investigation of alternative therapeutic approaches to address this ongoing health concern. In this study, PLGA-gold nanomaterials were produced through various processes to determine whether these variations affected their structural integrity and, consequently, their physicochemical properties. Methods: The PLGA-gold nanomaterials were produced through an oil-in-water (O/W) process (Formulation A) or a water-in-oil-in-water (W1/O/W2) process (Formulation B). The nanomaterials' physiscochemical properties were characterized by electron microscopy, dynamic light scattering, and UV-vis. Photothermal studies were performed using a 808 nm NIR laser and the PLGA-gold nanomaterials cytocompatibility was evaluated using resazurin. Results: Both methods originated particles with similar size and charge, 276.8 and –19.6 mV for formulation A and 317.5 nm and –18.6 mV for formulation B. Nevertheless, the TEM images revealed structural differences, with formulation A presenting the gold spheres clustered in the particle nucleus, whereas in formulation B the gold spheres were found in the outer PLGA shell. Moreover, upon irradiation with a NIR laser (808 nm, 1.7 W cm–2, 10 min), the particles showed a concentration dependent photothermal effect, promoting a temperature increase of 21 °C and 13.9 °C for formulation A and B at 400 μg/mL, respectively. Additionally, preliminary cellular assays demonstrated that the PLGA-gold nanoparticles are cytocompatible, with both FibH and HeLa cells exhibiting a cellular viability of approximately 100%. Conclusion: Thus, these results underline the potential the PLGA-gold nanoparticles, particularly formulation A, for advanced applications in nanomedicine. In the future the encapsulation of drugs will be evaluated in order to characterise both the uptake and the cytotoxic capacity of this multifunctional nanomaterial. Additionally, the utilization of more complex in vitro models, such as tumor spheroids and animal models, will then be essential to determine the therapeutic potential of PLGA/gold nanoparticles.
- Open Access
- 5 August 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 178, 214440
Beeswax-enriched tricalcium phosphate/hydroxyapatite/sodium alginate/thymol 3D-printed scaffolds for application in bone tissue engineering
- 5 August 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 178, 214440
Open AccessBeeswax-enriched tricalcium phosphate/hydroxyapatite/sodium alginate/thymol 3D-printed scaffolds for application in bone tissue engineering
- Open Access
- 7 July 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 177, 214405
Polydopamine-coated mesoporous silica/gold nanoclusters for enhanced chemo-photothermal therapy of cancer
- 7 July 2025
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 177, 214405
Open AccessPolydopamine-coated mesoporous silica/gold nanoclusters for enhanced chemo-photothermal therapy of cancer
- Open Access
- 16 June 2025
- Published by Elsevier in Materials & Design
- Vol. 256
Advancements and challenges in SLA-based microfluidic devices for organ-on-chip applications
- 16 June 2025
- Published by Elsevier in Materials & Design
- Vol. 256
Open AccessAdvancements and challenges in SLA-based microfluidic devices for organ-on-chip applications
- 6 May 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (11) , 1339-1353
Recent advances in smart gold nanoparticles for photothermal therapy
Gold nanoparticles (AuNPs) possess unique properties, including low toxicity and excellent optical characteristics, making them highly appealing for biomedical applications. The plasmonic photothermal effect of AuNPs has been explored to trigger localized hyperthermia. Four commonly explored gold nanoparticles (spheres, rods, stars, and cages) are produced and optimized to present the localized surface plasmon resonance effect in the near-infrared region, exploiting the increased penetration in the human body. Additionally, the production of hybrid AuNPs, combining them with other materials, such as silica, graphene, zinc oxide, polymers, and small molecules has been explored to amplify the photothermal effect (T ≥ 45ºC). This review provides an overview of AuNPs' application in photothermal therapy, describing the general synthesis processes and the main particle parameters that affect their application in photothermal therapy, including the hybrid nanomaterials. Associated with this rapid progress, surface functionalization can also improve colloidal stability, safety, and therapeutic outcomes. In this regard, we also highlight the emerging trend of applying cell-derived vesicles as biomimetic coatings, capable of evading immune recognition, increasing blood circulation, and targeting specific tissues. In addition, the challenges and future developments of AuNPs for accelerating the clinical translations are discussed in light of their therapeutic and theragnostic potential.
- 6 May 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (11) , 1339-1353
Recent advances in smart gold nanoparticles for photothermal therapy
Gold nanoparticles (AuNPs) possess unique properties, including low toxicity and excellent optical characteristics, making them highly appealing for biomedical applications. The plasmonic photothermal effect of AuNPs has been explored to trigger localized hyperthermia. Four commonly explored gold nanoparticles (spheres, rods, stars, and cages) are produced and optimized to present the localized surface plasmon resonance effect in the near-infrared region, exploiting the increased penetration in the human body. Additionally, the production of hybrid AuNPs, combining them with other materials, such as silica, graphene, zinc oxide, polymers, and small molecules has been explored to amplify the photothermal effect (T ≥ 45ºC). This review provides an overview of AuNPs' application in photothermal therapy, describing the general synthesis processes and the main particle parameters that affect their application in photothermal therapy, including the hybrid nanomaterials. Associated with this rapid progress, surface functionalization can also improve colloidal stability, safety, and therapeutic outcomes. In this regard, we also highlight the emerging trend of applying cell-derived vesicles as biomimetic coatings, capable of evading immune recognition, increasing blood circulation, and targeting specific tissues. In addition, the challenges and future developments of AuNPs for accelerating the clinical translations are discussed in light of their therapeutic and theragnostic potential.